Nosocomial Outbreak of COVID-19 from a Kidney Transplant Patient: Necessity of a Longer Isolation Period in Immunocompromised Patients
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Determination of the release from isolation for coronavirus disease 2019 (COVID-19) in immunocompromised patients who need additional hospitalization for treatment of non-COVID-19 related disease is important to prevent nosocomial transmission. However, there is insufficient evidence for an extended isolation period. Materials and Methods: In September 2021, when the Delta variant was dominant, a nosocomial outbreak of COVID-19 occurred in the nephrology ward of a tertiary hospital in Gwangju, Korea. We conducted epidemiological investigations and whole-genome sequencing (WGS) of this virus. Results: A man who underwent kidney transplantation was admitted to our hospital for the treatment of acute kidney injury. He was diagnosed with asymptomatic COVID-19 infection during a pre-admission screening test on September 1, 2021 and underwent isolation. After 10 days of isolation in the COVID-19-designated ward, he was transferred to the general nephrology ward. He underwent steroid pulse therapy (September 17 to September 23, >60 mg/day prednisolone) due to acute T-cell rejection. On September 28, 2021, the first patient with COVID-19 was identified in the nephrology ward, and a rapid-response team was activated to identify additional patients with COVID-19 and prevent the spread of COVID-19. Epidemiological investigations revealed that 12 patients, two caregivers, and three healthcare workers from the nephrology ward were diagnosed with COVID-19. The WGS of specimens from 14 nosocomial outbreak samples and released an index patient exhibited the same Delta variant originating from the B.1.617.2 lineage. This hospital-acquired COVID-19 outbreak in the nephrology ward resulted in two (11.7%) deaths in patients who underwent kidney transplantation. Conclusion: We demonstrated that an immunocompromised patient can cause a nosocomial outbreak due to the prolonged shedding of infectious viruses. Prolonged isolation in patients under active immunosuppressive therapy may be necessary to prevent transmission, especially in the hospital setting.
Abstract
Background: Determination of the release from isolation for coronavirus disease 2019 (COVID-19) in immunocompromised patients who need additional hospitalization for treatment of non-COVID-19 related disease is important to prevent nosocomial transmission. However, there is insufficient evidence for an extended isolation period. Materials and Methods: In September 2021, when the Delta variant was dominant, a nosocomial outbreak of COVID-19 occurred in the nephrology ward of a tertiary hospital in Gwangju, Korea. We conducted epidemiological investigations and whole-genome sequencing (WGS) of this virus. Results: A man who underwent kidney transplantation was admitted to our hospital for the treatment of acute kidney injury. He was diagnosed with asymptomatic COVID-19 infection during a pre-admission screening test on September 1, 2021 and underwent isolation. After 10 days of isolation in the COVID-19-designated ward, he was transferred to the general nephrology ward. He underwent steroid pulse therapy (September 17 to September 23, >60 mg/day prednisolone) due to acute T-cell rejection. On September 28, 2021, the first patient with COVID-19 was identified in the nephrology ward, and a rapid-response team was activated to identify additional patients with COVID-19 and prevent the spread of COVID-19. Epidemiological investigations revealed that 12 patients, two caregivers, and three healthcare workers from the nephrology ward were diagnosed with COVID-19. The WGS of specimens from 14 nosocomial outbreak samples and released an index patient exhibited the same Delta variant originating from the B.1.617.2 lineage. This hospital-acquired COVID-19 outbreak in the nephrology ward resulted in two (11.7%) deaths in patients who underwent kidney transplantation. Conclusion: We demonstrated that an immunocompromised patient can cause a nosocomial outbreak due to the prolonged shedding of infectious viruses. Prolonged isolation in patients under active immunosuppressive therapy may be necessary to prevent transmission, especially in the hospital setting.
참고문헌 (19)
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019(COVID-19) : A review", JAMA, 324, pp.782~793 (2020)
- Rhee C, "Duration of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infectivity : When is it safe to discontinue isolation?", Clin Infect Dis, 72, pp.1467~1474 (2021)
- He X, "Temporal dynamics in viral shedding and transmissibility of COVID-19", Nat Med, 26, pp.672~675 (2020)
- To KK, "Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2 : an observational cohort study", Lancet Infect Dis, 20, pp.565~574 (2020)
- Korea Disease Control and Prevention Agency (KDCA), "Guidelines for coronavirus infection-19. Updated 25 June 2020", KDCA, ~ (2020)
- Fung M, "COVID-19 in Immunocompromised Hosts : What we know so far", Clin Infect Dis, 72, pp.340~350 (2021)
- Hoang Tung, "Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis", Infection and Chemotherapy, 53(1), pp.13~28 (2021), 대한감염학회[DOI]
- Baragetti I, "Targeting immunity in endstage renal disease", Am J Nephrol, 45, pp.310~319 (2017)
- Lee Unhee, "Source Analysis and Effective Control of a COVID-19 Outbreak in a University Teaching Hospital during a Period of Increasing Community Prevalence of COVID-19", Journal of Korean Medical Science, 36(24), pp.1~13 (2021), 대한의학회[DOI]
- Baang JH, "Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient", J Infect Dis, 223, pp.23~27 (2021)
- "Isolation and precautions for people with COVID-19"[URL]
- "Guidance for living safely with respiratory infections, including coronavirus (COVID-19)"[URL]
- Jung Jiwon, "Nosocomial Outbreak of COVID-19 in a Hematologic Ward", Infection and Chemotherapy, 53(2), pp.332~341 (2021), 대한감염학회[DOI]
- Kim L, "Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019(COVID-19)-Associated hospitalization surveillance network(COVID-NET)", Clin Infect Dis, 72, pp.e206~14 (2021)
- Sabbatini AK, "Excess mortality among patients hospitalized during the COVID-19pandemic", J Hosp Med, 16, pp.596~602 (2021)
- van Kampen JJA, "Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019(COVID-19)", Nat Commun, 12, pp.267~ (2021)
- Taramasso L, "Duration of isolation and precautions in immunocompromised patients with COVID-19", J Hosp Infect, 111, pp.202~204 (2021)
- Leung WF, "COVID-19 in an immunocompromised host : persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations : a case report", Int J Infect Dis, 114, pp.178~182 (2022)
- Nakajima Y, "Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient", J Infect Chemother, 27, pp.387~389 (2021)